miR-195 inhibits glioma cell proliferation by downregulating expression of Cyclin D1 and cyclin E1, through directly targeting the 3′-UTR of Cyclin D1 and cyclin E1 [29]. This evidence concerns the gene CCND1 and central nervous system cancer.